Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Lori Anne Kunkel | Director | 2025-03-03 | 27,666 | $3.75 | $103.75kBuy |
Lori Anne Kunkel | Director | 2025-03-03 | 20,500 | $6.33 | $129.77kBuy |
Jacob Chacko | PRESIDENT AND CEO | 2024-12-16 | 24,660 | $8.28 | $204.21kSell |
Pratik S. Multani | Chief Medical Officer | 2024-12-16 | 8,850 | $8.28 | $73.30kSell |
Dominic Piscitelli | Chief Financial Officer | 2024-12-16 | 8,851 | $8.28 | $73.30kSell |
Lori Anne Kunkel | Director | 2024-06-03 | 20,500 | $3.75 | $76.88kBuy |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Pfizer Inc | 7.57% | 5,376,344 | $25.65M | Insider |
Pfizer Inc | 7.57% | 5,376,344 | $25.65M | Institution |
Nextech Invest Ltd | 7.44% | 5,285,714 | $25.21M | Institution |
Blackrock Inc | 7.20% | 5,113,034 | $24.39M | Institution |
Peter Svennilson | 6.71% | 4,768,181 | $22.74M | Insider |
Viking Global Investors LP | 6.24% | 4,431,008 | $21.14M | Institution |
Vr Adviser LLC | 6.19% | 4,394,527 | $20.96M | Institution |
Alkeon Capital Management LLC | 5.50% | 3,904,096 | $18.62M | Institution |
Frazier Life Sciences Management LP | 5.47% | 3,888,238 | $18.55M | Institution |
Column Group II LP | 5.02% | 3,568,255 | $17.02M | Insider |